Comparing two drugs for silent miscarriage management
Treatments studied
Part of Women’s health & pregnancy clinical trials.
This trial compares the effectiveness of two medications (letrozole and mifepristone with misoprostol) to help the body pass pregnancy tissue after a silent miscarriage. It may help women who prefer medical treatment over waiting or surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Diagnosed with a silent miscarriage at or before 12 weeks of pregnancy
- Only one gestational sac visible on ultrasound
- No heavy vaginal bleeding or severe abdominal pain currently
- No signs of uterine infection (like fever or foul discharge)
- Not allergic to mifepristone, misoprostol, or letrozole
- Not currently taking certain medications like blood thinners (e.g., aspirin, clopidogrel, anticoagulants)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether taking an aromatase inhibitor (letrozole) before misoprostol helps complete a miscarriage more effectively. It may offer a treatment option for people with a missed or early pregnancy loss.
This study compares two medications—letrozole plus misoprostol versus misoprostol alone—to see which is more effective for ending a pregnancy in the second trimester (14–20 weeks) after the fetus has stopped developing. The goal is to find a safer, more comfortable method for women who need this procedure.
This trial tests two different medicines (Mifepristone vs Misoprostol) to see which works better for ending a pregnancy in the second trimester (12–16 weeks). It is for people who are pregnant with one baby and have no major health issues that could affect safety.
This trial tests whether adding letrozole (a hormone pill) to misoprostol (a medicine to complete a miscarriage) works better than misoprostol alone for ending a missed miscarriage in early pregnancy. It aims to make the process safer and possibly faster.
This study compares two ways of taking medicine (by mouth or vaginal insertion) to safely manage a miscarriage that was discovered on ultrasound between 8–16 weeks of pregnancy. The goal is to see which method works better and causes fewer side effects.
This trial tests whether taking letrozole before misoprostol shortens the time needed to complete a missed abortion, which is when the pregnancy stops developing but the body hasn't expelled the tissue. If effective, it could reduce the waiting time and make the process more efficient.
Hear when a new Silent Miscarriage trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.